2009 Palm Beach Symposium

Evelyn H. Lauder
Founder and Chairman, The Breast Cancer Research Foundation

Panel Moderator:

Larry Norton, MD
Chairman, BCRF Executive Board of Scientific Advisors
Deputy Physician-in-Chief of Memorial Hospital; Director of Breast Cancer Programs, Memorial Sloan-Kettering Cancer Center, New York, NY

Panelists:

Mark E. Lippman, MD
Kathleen & Stanley Glaser Professor; Chairman, Department of Medicine
Miller School of Medicine, University of Miami, Miami, FL

Clifford Hudis, MD
Chairman, BCRF Scientific Advisory Committee
Chief, Breast Cancer Medicine Service and Attending Physician
Memorial Sloan-Kettering Cancer Center, New York, NY

William G. Kaelin, Jr., MD
Professor of Medicine, Howard Hughes Medical Institute
Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

Kornelia Polyak, MD, PhD
Associate Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Q&A Topics and Discussion:

How do tamoxifen and aromatase inhibitors differ?
Response by:
Marc Lippman, MD (Panelist)

How do breast cancer "stem cells" work?
Response by:
Kornelia Polyak, MD, PhD (Panelist)

Why is it taking so long to find a cure for breast cancer? Do scientists share their results? [rather than sharing information]
Response by:
William Kaelin, MD (Panelist)

When should a prophylactic removal of ovaries be considered?
Response by:
Marc Lippman, MD (Panelist)
Introduction by: Larry Norton, MD (Moderator)

Genetic advances make possible individualized treatment
Response by:
Larry Norton, MD (Moderator)

Approaches to breast cancer prevention
Response by:
William Kaelin, MD (Panelist)
Clifford Hudis, MD (Panelist)
Kornelia Polyak, MD, PhD (Panelist)
Marc Lippman, MD (Panelist)

Targeted therapies will replace systemic chemotherapy
Response by:
William Kaelin, MD (Panelist)

Breast cancer risk factors
Response by:
Marc Lippman, MD (Panelist)
Larry Norton, MD (Moderator)

Targeted therapies
Response by:
Kornelia Polyak, MD, PhD (Panelist)
Larry Norton, MD (Moderator)

Reconciling tumor heterogeneity and divergent outcomes
Response by:
Clifford Hudis, MD (Panelist)
Kornelia Polyak, MD, PhD (Panelist)
Introduction by: Larry Norton, MD (Moderator)

Tumor inhibitors/how new drugs are developed
Response by:
Clifford Hudis, MD (Panelist)
Comments by: Larry Norton, MD (Moderator) - off camera

Do cancer growth rates slow as aging progresses?
Response by:
Clifford Hudis, MD (Panelist)